Article Information
History
- January 26, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Patricia C. Lloyd, PhD, ScM1,*,
- Elizabeth R. Smith, BS2,
- Joann F. Gruber, PhD, MSPH1,
- Michelle Ondari, MSPH2,
- Hui Lee Wong, PhD1,
- Mao Hu, BS2,
- Tainya C. Clarke, PhD, MPH, MSc1,
- Rowan McEvoy, BS2,
- Kandace L. Amend, PhD, MPH3,
- Daniel C. Beachler, PhD, MHS4,
- Cheryl N McMahill-Walraven, PhD, MSW6,
- John D. Seeger, DrPH, PharmD3,
- Alex Secora, PhD5,
- Djeneba Audrey Djibo, PhD6,
- Jennifer Song, MA, MURP3,
- Nandini Selvam, PhD, MPH5,
- Jonathan P. DeShazo, PhD, MPH6,
- Robin Clifford, MS3,
- Eugenio Abente, PhD6,
- Yoganand Chillarige, MPA2,
- Richard A. Forshee, PhD1,
- Steven A. Anderson, PhD, MPP1 and
- Azadeh Shoaibi, PhD, MHS7
- 1US Food and Drug Administration, Silver Spring, MD, USA
- 2Acumen LLC, Burlingame, CA, USA
- 3Optum Epidemiology, Boston, MA, USA
- 4Carelon, Wilmington, DE, USA
- 5IQVIA, Falls Church, VA, USA
- 6CVS Health Clinical Trial Services, Blue Bell, PA, USA
- 7Affiliated with the US Food and Drug Administration, Silver Spring, MD, USA during the conduct of this work
- ↵*Corresponding Author:
Patricia C. Lloyd, PhD, ScM, Health Statistician, Office of Biostatistics and Pharmacovigilance, Center for Biologics Evaluation and Research, U.S. Food & Drug Administration, 10903 New Hampshire Ave., Building 71, Silver Spring, MD 20993, Email: patricia.lloyd{at}fda.hhs.gov
Posted January 26, 2024.
Safety Monitoring of Bivalent COVID-19 mRNA Vaccines Among Recipients 6 months and Older in the United States
